Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05670444

Melatonin, Vitamins and Minerals Supplements for the Treatment of Covid-19 and Covid-like Illness

Conditions: Influenza -Like Illness

Sex: All
Ages: 18 Years – 60 Years
Phase: PHASE1
Enrollment: 150
Sponsor: Hôpital Universitaire Sahloul

Location: Tunisia

Summary

a multicenter, double-blind, randomized, placebo-controlled trial. Patients aged less than 60 years old with no previous medical history consulting the emergency department for covid and covid-like illness and who were not hospitalized were included. Those who have known allergy or severe side effect on the study drugs and those who refused to consent were excluded. Pregnant women were not included. For all the included patients, a PCR test for the detection of SARS COV2 was realized. Patients were assigned in a 1:1 ratio to the treatment group or the placebo group. The treatment group received two pills in the morning containing Vit C Vit D zinc and minerals and one pill of 2 mg of melatonin in the evening . Patients from the placebo group received three similar pills . The pills were identical in color, taste, smell, consistency, and container

Eligibility Criteria

Inclusion Criteria:Patients aged less than 60 years old with no previous medical history consulting the emergency department for covid and covid-like illness and who were not hospitalized were includedExclusion Criteria:Those who have known allergy or severe side effect on the study drugs and those who refused to consent were excluded. Pregnant women were not included

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05670444). StuddyBuddy aggregates publicly available trial information.